In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody

Pancreatic cancer is a highly malignant disease with a 5-year survival rate

Saved in:
Bibliographic Details
Published in:International journal of nanomedicine 2016-01, Vol.11, p.2195-2207
Main Authors: Liu, Fang, Le, Wenjun, Mei, Tianxiao, Wang, Tiegong, Chen, Luguang, Lei, Yi, Cui, Shaobin, Chen, Bingdi, Cui, Zheng, Shao, Chengwei
Format: Article
Language:English
Subjects:
Animals
Antibodies - pharmacology
Apoptosis
Biocompatibility
Biomarkers
Cell Death - drug effects
Cell Line, Tumor
Cell Survival - drug effects
Dextrans - chemistry
Drug Delivery Systems
Flow Cytometry
Gastroenterology
Gene expression
GPI-Linked Proteins - immunology
Hospitals
Humans
Iron - metabolism
Labeling
Laboratory animals
Magnetic Resonance Imaging
Magnetite Nanoparticles - chemistry
Male
Medical prognosis
Mice, Inbred BALB C
Mice, Nude
Molecular weight
Motility
Nanoparticles
Nanoparticles - chemistry
Nanoparticles - ultrastructure
NMR
Nuclear magnetic resonance
Original Research
Pancreatic cancer
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - ultrastructure
Pancreatitis
Pathogens
Polyethylene glycol
Silicon Dioxide - chemistry
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pancreatic cancer is a highly malignant disease with a 5-year survival rate
ISSN:1178-2013
1176-9114
1178-2013
DOI:10.2147/IJN.S104501